145 related articles for article (PubMed ID: 23291749)
21. Suppression of gingival inflammation induced by Porphyromonas gingivalis in rats by leupeptin.
Kitano S; Irimura K; Sasaki T; Abe N; Baba A; Miyake Y; Katunuma N; Yamamoto K
Jpn J Pharmacol; 2001 Jan; 85(1):84-91. PubMed ID: 11243579
[TBL] [Abstract][Full Text] [Related]
22. Noncanonical activation of β-catenin by Porphyromonas gingivalis.
Zhou Y; Sztukowska M; Wang Q; Inaba H; Potempa J; Scott DA; Wang H; Lamont RJ
Infect Immun; 2015 Aug; 83(8):3195-203. PubMed ID: 26034209
[TBL] [Abstract][Full Text] [Related]
23. Secreted gingipains from Porphyromonas gingivalis colonies exert potent immunomodulatory effects on human gingival fibroblasts.
Bengtsson T; Khalaf A; Khalaf H
Microbiol Res; 2015 Sep; 178():18-26. PubMed ID: 26302843
[TBL] [Abstract][Full Text] [Related]
24. Altered T-cell responses by the periodontal pathogen Porphyromonas gingivalis.
Khalaf H; Bengtsson T
PLoS One; 2012; 7(9):e45192. PubMed ID: 22984628
[TBL] [Abstract][Full Text] [Related]
25. Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase.
Naito M; Sakai E; Shi Y; Ideguchi H; Shoji M; Ohara N; Yamamoto K; Nakayama K
Mol Microbiol; 2006 Jan; 59(1):152-67. PubMed ID: 16359325
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of macrocarpals on the biological activity of Porphyromonas gingivalis and other periodontopathic bacteria.
Nagata H; Inagaki Y; Yamamoto Y; Maeda K; Kataoka K; Osawa K; Shizukuishi S
Oral Microbiol Immunol; 2006 Jun; 21(3):159-63. PubMed ID: 16626372
[TBL] [Abstract][Full Text] [Related]
27. Gingipain adhesin domains mediate Porphyromonas gingivalis adherence to epithelial cells.
Chen T; Duncan MJ
Microb Pathog; 2004 Apr; 36(4):205-9. PubMed ID: 15001226
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of protamines on proteolytic and adhesive activities of Porphyromonas gingivalis.
Kontani M; Amano A; Nakamura T; Nakagawa I; Kawabata S; Hamada S
Infect Immun; 1999 Sep; 67(9):4917-20. PubMed ID: 10456950
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
Grenier D; Plamondon P; Sorsa T; Lee HM; McNamara T; Ramamurthy NS; Golub LM; Teronen O; Mayrand D
J Periodontol; 2002 Jan; 73(1):79-85. PubMed ID: 11846203
[TBL] [Abstract][Full Text] [Related]
30. The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibition.
Yongqing T; Potempa J; Pike RN; Wijeyewickrema LC
Adv Exp Med Biol; 2011; 712():15-29. PubMed ID: 21660656
[TBL] [Abstract][Full Text] [Related]
31. Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis.
Yun PL; DeCarlo AA; Hunter N
Infect Immun; 1999 Jun; 67(6):2986-95. PubMed ID: 10338509
[TBL] [Abstract][Full Text] [Related]
32. Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct types of Porphyromonas gingivalis fimbriae.
Nakagawa I; Inaba H; Yamamura T; Kato T; Kawai S; Ooshima T; Amano A
Infect Immun; 2006 Jul; 74(7):3773-82. PubMed ID: 16790749
[TBL] [Abstract][Full Text] [Related]
33. Autolysis of Porphyromonas gingivalis is accompanied by an increase in several periodontal pathogenic factors in the supernatant.
Kamaguchi A; Nakano M; Shoji M; Nakamura R; Sagane Y; Okamoto M; Watanabe T; Ohyama T; Ohta M; Nakayama K
Microbiol Immunol; 2004; 48(7):541-5. PubMed ID: 15272200
[TBL] [Abstract][Full Text] [Related]
34. Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.
Ho MH; Lamont RJ; Chazin WJ; Chen H; Young DF; Kumar P; Xie H
Mol Oral Microbiol; 2018 Dec; 33(6):430-439. PubMed ID: 30298683
[TBL] [Abstract][Full Text] [Related]
35. Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.
Castro SA; Collighan R; Lambert PA; Dias IH; Chauhan P; Bland CE; Milic I; Milward MR; Cooper PR; Devitt A
Cell Death Dis; 2017 Mar; 8(3):e2644. PubMed ID: 28252646
[TBL] [Abstract][Full Text] [Related]
36. Roles for Arg- and Lys-gingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection.
Baba A; Kadowaki T; Asao T; Yamamoto K
Biol Chem; 2002; 383(7-8):1223-30. PubMed ID: 12437109
[TBL] [Abstract][Full Text] [Related]
37. The collagenase activity of Porphyromonas gingivalis is due to Arg-gingipain.
Houle MA; Grenier D; Plamondon P; Nakayama K
FEMS Microbiol Lett; 2003 Apr; 221(2):181-5. PubMed ID: 12725924
[TBL] [Abstract][Full Text] [Related]
38. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
[TBL] [Abstract][Full Text] [Related]
39. Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals.
Goulet V; Britigan B; Nakayama K; Grenier D
Infect Immun; 2004 Aug; 72(8):4351-6. PubMed ID: 15271890
[TBL] [Abstract][Full Text] [Related]
40. Selective proteolysis of apolipoprotein B-100 by Arg-gingipain mediates atherosclerosis progression accelerated by bacterial exposure.
Hashimoto M; Kadowaki T; Tsukuba T; Yamamoto K
J Biochem; 2006 Nov; 140(5):713-23. PubMed ID: 17030507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
